71.4% and 69.2% of patients treated with zasocitinib achieved a static Physician Global Assessment (sPGA) score of 0/1 versus placebo (10.7% and 12.6%) and apremilast (32.1% and 29.7%) at week 16 (p<0 ...
Abstract: The study investigates the problem of attack-compensated control for two-dimensional (2-D) fuzzy systems modeled by the Roesser framework, subject to the constraints of limited communication ...